| 000 | 01762 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516015914.0 | ||
| 264 | 0 | _c20110930 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1573-7209 | ||
| 024 | 7 |
_a10.1007/s10456-010-9197-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWalraven, Maudy | |
| 245 | 0 | 0 |
_aAntiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review. _h[electronic resource] |
| 260 |
_bAngiogenesis _cMay 2011 |
||
| 300 |
_a135-41 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aBenzenesulfonates _xadverse effects |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 | _aEndoscopy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xadverse effects |
| 650 | 0 | 4 |
_aIntestinal Perforation _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPyridines _xadverse effects |
| 650 | 0 | 4 |
_aPyrroles _xadverse effects |
| 650 | 0 | 4 | _aRadiography |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aSunitinib |
| 700 | 1 | _aWitteveen, Petronella O | |
| 700 | 1 | _aLolkema, Martijn P J | |
| 700 | 1 | _avan Hillegersberg, R | |
| 700 | 1 | _aVoest, Emile E | |
| 700 | 1 | _aVerheul, H M W | |
| 773 | 0 |
_tAngiogenesis _gvol. 14 _gno. 2 _gp. 135-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10456-010-9197-6 _zAvailable from publisher's website |
| 999 |
_c20475540 _d20475540 |
||